Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liminal BioSciences Inc. - Common Shares (NQ: LMNL )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 8.430 (1)
Ask (Size) 8.500 (25)
Prev. Close 8.500
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 31,042,560
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
Liminal BioSciences Stock Gains0% Today - Here's Why?
Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Management, agreed to  
Via Benzinga

Performance

More News

Read More
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Liminal BioSciences Pulls Plug On Its Lead Development Program
Via Benzinga
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
Via Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
Via Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Liminal Biosciences Inc. (NASDAQ: LMNL) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
Via Benzinga
Why Is Freight Technologies (FRGT) Stock Up 25% Today?
Via InvestorPlace
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
Via InvestorPlace
Markets Mixed; US Trade Deficit Widens In February
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Earnings Scheduled For March 15, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Via Benzinga
Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound
Via Benzinga
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
Via InvestorPlace
Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.